Revance Therapeutics, Inc.
Overview
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product known as DaxibotulinumtoxinA. The company aims to redefine patient and physician competencies in the field of neuromodulation.
Therapeutic areas
AestheticsNeurology
FDA compliance signals
1 FDA enforcement record linked to this company.
- 4832025-02-27
Scientifically sound laboratory controls
Verified Supplier Partner
Is this Revance Therapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.